vTv Therapeutics Inc.VTVTNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank92
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P92
Near historical high
vs 2Y Ago
5.5x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202554.69%
2024-15.07%
202310.02%
2022-7.26%
202120.96%
2020-27.14%
2019-34.37%
2018-41.89%
2017-13.35%
201654.64%